- $26.33m
- $29.87m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 2.85 | 7.92 | 3 | 0.349 | 0.078 |
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Other Assets | |||||
Total Assets | 13.6 | 7.99 | 3.08 | 0.41 | 0.078 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.414 | 0.383 | 0.684 | 1.48 | 6.42 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 13.2 | 7.61 | 2.4 | -1.07 | -6.34 |
Total Liabilities & Shareholders' Equity | 13.6 | 7.99 | 3.08 | 0.41 | 0.078 |
Total Common Shares Outstanding |